Citius Pharmaceuticals, Inc. Annual Depreciation in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Citius Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from 2016 to 2023.
  • Citius Pharmaceuticals, Inc. Depreciation for the quarter ending December 31, 2023 was $578.000, a 20.8% decline year-over-year.
  • Citius Pharmaceuticals, Inc. annual Depreciation for 2023 was $2.67K, a 8.72% decline from 2022.
  • Citius Pharmaceuticals, Inc. annual Depreciation for 2022 was $2.92K, a 95.9% increase from 2021.
  • Citius Pharmaceuticals, Inc. annual Depreciation for 2021 was $1.49K, a 76.8% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.67K -$255 -8.72% Oct 1, 2022 Sep 30, 2023 10-K 2023-12-29
2022 $2.92K +$1.43K +95.9% Oct 1, 2021 Sep 30, 2022 10-K 2023-12-29
2021 $1.49K +$648 +76.8% Oct 1, 2020 Sep 30, 2021 10-K 2022-12-22
2020 $844 -$49 -5.49% Oct 1, 2019 Sep 30, 2020 10-K 2021-12-15
2019 $893 -$860 -49.1% Oct 1, 2018 Sep 30, 2019 10-K 2020-12-16
2018 $1.75K -$879 -33.4% Oct 1, 2017 Sep 30, 2018 10-K 2019-12-16
2017 $2.63K +$1.29K +96% Oct 1, 2016 Sep 30, 2017 10-K 2019-12-16
2016 $1.34K Oct 1, 2015 Sep 30, 2016 10-K 2018-12-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.